| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |